{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:33Z","timestamp":1761986553586,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K43TW011178-01"],"award-info":[{"award-number":["K43TW011178-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaip.2021.03.043","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T17:29:45Z","timestamp":1619285385000},"page":"2220-2228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chronic Urticaria and Recurrent Angioedema: Clues to the Mimics"],"prefix":"10.1016","volume":"9","author":[{"given":"Jonathan","family":"Peter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Staubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena Alessandra","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.03.043_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fmed.2019.00089","article-title":"Paroxysmal permeability disorders: development of a microfluidic device to assess endothelial barrier function","volume":"6","author":"Wu","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2021.03.043_bib2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2500\/aap.2020.41.200058","article-title":"Triggers and short-term prophylaxis in patients with hereditary angioedema","volume":"41","author":"Craig","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2021.03.043_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1684\/ejd.2019.3674","article-title":"Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response","volume":"29","author":"Curto-Barredo","year":"2019","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaip.2018.03.007","article-title":"How to approach chronic inducible urticaria","volume":"6","author":"Maurer","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.043_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Gon\u00e7alo","year":"2021","journal-title":"Br J Dermato"},{"key":"10.1016\/j.jaip.2021.03.043_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anai.2019.08.014","article-title":"New treatments for chronic urticaria","volume":"124","author":"Kolkhir","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaip.2018.04.022","article-title":"Angioedema due to bradykinin dysregulation","volume":"6","author":"Cicardi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.043_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.03.043_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/all.12153","article-title":"Practical algorithm for diagnosing patients with recurrent wheals or angioedema","volume":"68","author":"Maurer","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.03.043_bib10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/all.12030","article-title":"How not to miss autoinflammatory diseases masquerading as urticaria","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.03.043_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2015-0195","article-title":"The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity","volume":"54","author":"Wu","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2021.03.043_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N\u00a0Engl J Med"},{"author":"Ollitrault","key":"10.1016\/j.jaip.2021.03.043_bib13"},{"key":"10.1016\/j.jaip.2021.03.043_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bjophthalmol-2014-305545","article-title":"An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD","volume":"99","author":"Andrew","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaip.2021.03.043_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000445835","article-title":"How not to be misled by disorders mimicking angioedema: a review of pseudoangioedema","volume":"169","author":"Andersen","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/ijerph16071289","article-title":"Melkersson(-)Rosenthal syndrome in childhood: report of three paediatric cases and a review of the literature","volume":"16","author":"Savasta","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jaip.2021.03.043_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/IJGM.S186315","article-title":"Management strategies of Melkersson-Rosenthal syndrome: a review","volume":"13","author":"Dhawan","year":"2020","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jaip.2021.03.043_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1573396314666180515113941","article-title":"A\u00a0systematic review of the literature of the three related disease entities cheilitis granulomatosa, orofacial granulomatosis and Melkersson-Rosenthal syndrome","volume":"14","author":"Wehl","year":"2018","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.jaip.2021.03.043_bib19","first-page":"25","article-title":"Episodic angioedema associated with eosinophilia","volume":"97","author":"Gleich","year":"1984","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.jaip.2021.03.043_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/pai.13173","article-title":"Episodic angioedema with eosinophilia (Gleich syndrome) in children: a clinical review","volume":"31","author":"Bertrand","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"author":"Abisror","key":"10.1016\/j.jaip.2021.03.043_bib21"},{"key":"10.1016\/j.jaip.2021.03.043_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000018025","article-title":"Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan","volume":"197","author":"Chikama","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2021.03.043_bib23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fimmu.2018.01198","article-title":"Efficacy and safety of mepolizumab (anti-interleukin-5) treatment in Gleich\u2019s syndrome","volume":"9","author":"Matucci","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4168\/aair.2020.12.2.371","article-title":"Non-episodic angioedema with eosinophilia successfully treated with reslizumab","volume":"12","author":"Chu","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2021.03.043_bib25","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of urticaria: urticarial vasculitis and autoinflammatory diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.03.043_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clindermatol.2016.02.011","article-title":"Polymorphic eruption of pregnancy","volume":"34","author":"Taylor","year":"2016","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib28","first-page":"FR49","article-title":"Hypocomplementemic urticarial vasculitis syndrome: a rare but not always benign condition [in Swedish]","volume":"116","author":"Sj\u00f6wall","year":"2019","journal-title":"Lakartidningen"},{"key":"10.1016\/j.jaip.2021.03.043_bib29","first-page":"340","article-title":"Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome","volume":"48","author":"McDuffie","year":"1973","journal-title":"Mayo Clin Proc"},{"issue":"Pt 2","key":"10.1016\/j.jaip.2021.03.043_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: a histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.38956","article-title":"The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0002-9343(80)90216-8","article-title":"A\u00a0hypocomplementemic vasculitic urticarial syndrome. Report of four new cases and definition of the disease","volume":"68","author":"Zeiss","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2021.03.043_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0738-081X(99)00062-0","article-title":"Urticarial vasculitis","volume":"17","author":"Black","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib34","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/rheumatology\/key110","article-title":"Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)","volume":"57","author":"Sj\u00f6wall","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2021.03.043_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(24)00193-2","article-title":"Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis","volume":"38","author":"Davis","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2021.03.043_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: a systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e3283574d0c","article-title":"The role of interleukin-1 in allergy-related disorders","volume":"12","author":"Krause","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler's syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.03.043_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.15705","article-title":"Use of skin biomarker profiles to distinguish Schnitzler syndrome from chronic spontaneous urticaria: results of a pilot study","volume":"178","author":"Bonnekoh","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2021.03.043_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","article-title":"Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study","volume":"139","author":"Krause","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A\u00a0comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2021.03.043_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"issue":"Suppl 6","key":"10.1016\/j.jaip.2021.03.043_bib44","doi-asserted-by":"crossref","first-page":"vi9","DOI":"10.1093\/rheumatology\/kez350","article-title":"Anakinra in children and adults with Still's disease","volume":"58","author":"Vastert","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2021.03.043_bib45","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.03.043_bib46","doi-asserted-by":"crossref","first-page":"adv00091","DOI":"10.2340\/00015555-3427","article-title":"Spectrum of genetic autoinflammatory diseases presenting with cutaneous symptoms","volume":"100","author":"Bonnekoh","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2021.03.043_bib47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.03.043_bib48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2021.03.043_bib49","doi-asserted-by":"crossref","unstructured":"Matito A, Escribese MM, Longo N, Mayorga C, Luengo-S\u00e1nchez O, P\u00e9rez-Gordo M, et\u00a0al. Clinical approach to mast cell activation syndromes: a practical overview [published online ahead of print February 4, 2021]. J Investig Allergol Clin Immunol. https:\/\/doi.org\/10.18176\/jiaci.0675.","DOI":"10.18176\/jiaci.0675"},{"key":"10.1016\/j.jaip.2021.03.043_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.03.043_bib51","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.3390\/ijms21239030","article-title":"Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine","volume":"21","author":"Valent","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2021.03.043_bib52","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.03.043_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/dx-2020-0005","article-title":"Diagnosis of mast cell activation syndrome: a global \"consensus-2\"","volume":"8","author":"Afrin","year":"2021","journal-title":"Diagnosis (Berl)"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821004281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821004281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:26:53Z","timestamp":1761974813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821004281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213219821004281"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.03.043","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Urticaria and Recurrent Angioedema: Clues to the Mimics","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}